ArticleBMJ open2023

Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial.

Jing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.